A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
సెన్సెక్స్
73,852.90
▼ -1.17%
నిప్టీ
22,888.95
▼ -1.11%
బంగారం
₹ 13,570/gm
సిల్వర్
₹ 2,40,000/kg
పెట్రోల్
₹ 116.15
డీజిల్
₹ 104.23
ఎల్పీజీ
₹ 994.00
ముడి చమురు
$ 108.74
USD
₹ 94.92
సెన్సెక్స్
73,852.90
▼ -1.17%
నిప్టీ
22,888.95
▼ -1.11%
బంగారం
₹ 13,570/gm
సిల్వర్
₹ 2,40,000/kg
పెట్రోల్
₹ 116.15
డీజిల్
₹ 104.23
ఎల్పీజీ
₹ 994.00
ముడి చమురు
$ 108.74
USD
₹ 94.92
HDFC Pharma and Healthcare Fund
Regular
Direct
3 Year Absolute Returns
104.54% ↑
NAV (₹) on 16 Oct 2026
20.48
1 Day NAV Change
0.02%
Risk Level
Very High Risk
Rating
-
HDFC Pharma and Healthcare Fund is a Equity mutual fund categorized under Sector, offered by HDFC Asset Management Company Ltd.. Launched on 14 Sep 2023, investors can start with a minimum SIP of ₹100 ... Read more
NAV History
Fund Details
Min. SIP Amount
₹100
Inception Date
14 Sep 2023
Min. Lumpsum Amount
₹ 100
Fund Age
3 Yrs
AUM
₹ 3,501.37 Cr.
Benchmark
BSE Healthcare
Expense Ratio
2.11%
Scheme Type
Open Ended
Exit Load
1%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 3,501.37 Cr
Equity
96.77%
Money Market & Cash
4.67%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 72.28% |
| Hospitals & Medical Services | 24.14% |
| Treps/Reverse Repo | 4.67% |
| Medical Equipment & Accessories | 0.35% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Divis Laboratories Ltd. | 9.39% | ₹ 328.63 | Pharmaceuticals |
| Sun Pharmaceutical Industries Ltd. | 8.28% | ₹ 289.76 | Pharmaceuticals |
| TREPS - Tri-party Repo | 4.67% | ₹ 163.43 | Others |
| Alkem Laboratories Ltd. | 4.64% | ₹ 162.58 | Pharmaceuticals |
| Cipla Ltd. | 4.15% | ₹ 145.37 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 3.69% | ₹ 129.18 | Hospitals & Medical Services |
| Torrent Pharmaceuticals Ltd. | 3.65% | ₹ 127.91 | Pharmaceuticals |
| Max Healthcare Institute Limited | 3.61% | ₹ 126.42 | Hospitals & Medical Services |
| Aster DM Quality Care Limited | 3.56% | ₹ 124.51 | Hospitals & Medical Services |
| Lupin Ltd. | 3.55% | ₹ 124.15 | Pharmaceuticals |
| Neuland Laboratories Limited | 3.24% | ₹ 113.51 | Pharmaceuticals |
| Shilpa Medicare Ltd | 3.23% | ₹ 113.18 | Pharmaceuticals |
| Dr Reddys Laboratories Ltd. | 3.19% | ₹ 111.58 | Pharmaceuticals |
| Acutaas Chemicals Limited | 3.18% | ₹ 111.17 | Pharmaceuticals |
| Anthem Biosciences Limited | 3.17% | ₹ 110.90 | Pharmaceuticals |
| Ipca Laboratories Ltd. | 2.98% | ₹ 104.39 | Pharmaceuticals |
| Global Health Limited | 2.72% | ₹ 95.30 | Hospitals & Medical Services |
| Rubicon Research Limited | 2.52% | ₹ 88.16 | Pharmaceuticals |
| Krishna Institute Of Medical Sciences Limited | 2.10% | ₹ 73.50 | Hospitals & Medical Services |
| Glenmark Pharmaceuticals Ltd. | 2.09% | ₹ 73.05 | Pharmaceuticals |
| Molbio Diagnostics Limited | 2.01% | ₹ 70.42 | Hospitals & Medical Services |
| Vijaya Diagnostic Centre Limited | 2.00% | ₹ 70.17 | Hospitals & Medical Services |
| Zydus Lifesciences Limited | 1.82% | ₹ 63.78 | Pharmaceuticals |
| Gland Pharma Ltd. | 1.78% | ₹ 62.32 | Pharmaceuticals |
| Wockhardt Ltd. | 1.71% | ₹ 59.95 | Pharmaceuticals |
| Jupiter Life Line Hospitals Limited | 1.68% | ₹ 58.95 | Hospitals & Medical Services |
| Metropolis Healthcare Ltd. | 1.67% | ₹ 58.58 | Hospitals & Medical Services |
| Sai Life Sciences Limited | 1.58% | ₹ 55.18 | Pharmaceuticals |
| Biocon Ltd. | 1.47% | ₹ 51.49 | Pharmaceuticals |
| SYMBIOTEC PHARMALAB LIMITED | 1.36% | ₹ 47.64 | Pharmaceuticals |
| Thyrocare Technologies Ltd. | 1.10% | ₹ 38.41 | Hospitals & Medical Services |
| CORONA REMEDIES LIMITED | 1.04% | ₹ 36.29 | Pharmaceuticals |
| Entero Healthcare Solutions Limited | 1.01% | ₹ 35.37 | Pharmaceuticals |
| Jubilant Pharmova Limited | 0.93% | ₹ 32.67 | Pharmaceuticals |
| Eris Lifesciences Ltd | 0.92% | ₹ 32.34 | Pharmaceuticals |
| Novartis India Ltd. | 0.55% | ₹ 19.31 | Pharmaceuticals |
| BAJAJ HEALTHCARE LIMITED | 0.53% | ₹ 18.61 | Pharmaceuticals |
| Laxmi Dental Limited | 0.35% | ₹ 12.34 | Medical Equipment & Accessories |
| Cohance Lifesciences Limited | 0.32% | ₹ 11.10 | Pharmaceuticals |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 20.18% | 18.60% | 11.56% | 26.94% |
| Category returns | 2.63% | 1.26% | 1.45% | 19.51% |
Fund Objective
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of ... Read more
AMC Details
Name
HDFC Asset Management Company Ltd.
Date of Incorporation
30 Jun 2000
CEO
Mr. Navneet Munot
CIO
Type
Pvt.Sector-Joint Venture (Indian)
Address
HDFC House, 2nd Floor,
H T Parekh Marg,
165-166,
Backbay Reclamation,
Churchgate, Mumbai, Maharashtra, India - 400020
Website
http://www.hdfcfund.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.25 | 102.19% | 288.92% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.25 | 102.19% | 288.92% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹35.25 | 102.19% | 288.92% | 0.00% | ₹1,147 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.87 | 99.51% | 273.25% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.87 | 99.51% | 273.25% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹32.87 | 99.51% | 273.25% | 0.00% | ₹1,147 | 2.34% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.29 | 19.52% | 147.34% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.29 | 19.52% | 147.34% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.29 | 19.52% | 147.34% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.19 | 18.38% | 139.48% | 0.00% | ₹11,493 | 1.79% |
Very High
|
Top Funds from HDFC Asset Management Company Ltd.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
HDFC Silver ETF
ETF
Regular
|
₹199.72 | 23.13% | 188.77% | 0.00% | ₹7,724 | 0.50% |
Very High
|
|
HDFC Silver ETF Fund of Fund - Direct Plan
Fund of Funds
Direct
|
₹34.51 | 26.67% | 182.16% | 0.00% | ₹4,497 | 0.21% |
Very High
|
|
HDFC Silver ETF Fund of Fund
Fund of Funds
Regular
|
₹34.01 | 26.17% | 179.23% | 0.00% | ₹4,497 | 0.55% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.29 | 19.52% | 147.34% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.29 | 19.52% | 147.34% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.29 | 19.52% | 147.34% | 0.00% | ₹11,493 | 0.89% |
Very High
|
|
HDFC Gold ETF
ETF
Regular
|
₹123.99 | 14.15% | 140.47% | 190.10% | ₹23,900 | 0.59% |
High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.19 | 18.38% | 139.48% | 0.00% | ₹11,493 | 1.79% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.19 | 18.38% | 139.48% | 0.00% | ₹11,493 | 1.79% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.19 | 18.38% | 139.48% | 0.00% | ₹11,493 | 1.79% |
Very High
|
FAQs
What is the current NAV of HDFC Pharma and Healthcare Fund Regular IDCW?
The current Net Asset Value (NAV) of HDFC Pharma and Healthcare Fund Regular IDCW is ₹20.48 as of 16 Oct 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of HDFC Pharma and Healthcare Fund Regular IDCW?
The Assets Under Management (AUM) of HDFC Pharma and Healthcare Fund Regular IDCW is ₹3,501.37 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of HDFC Pharma and Healthcare Fund Regular IDCW?
HDFC Pharma and Healthcare Fund Regular IDCW has delivered returns of 18.60% (1 Year), 26.94% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of HDFC Pharma and Healthcare Fund Regular IDCW?
HDFC Pharma and Healthcare Fund Regular IDCW has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for HDFC Pharma and Healthcare Fund Regular IDCW?
The minimum lumpsum investment required for HDFC Pharma and Healthcare Fund Regular IDCW is ₹100. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹100, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+